ACE2 Citations (5)

Originally described in: Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
Yang Q, Hughes TA, Kelkar A, Yu X, Cheng K, Park S, Huang WC, Lovell JF, Neelamegham S Elife. 2020 Oct 26;9. pii: 61552. doi: 10.7554/eLife.61552. PubMed Journal

---

Articles Citing ACE2

Articles
Role for N-glycans and calnexin-calreticulin chaperones in SARS-CoV-2 Spike maturation and viral infectivity. Yang Q, Kelkar A, Sriram A, Hombu R, Hughes TA, Neelamegham S. Sci Adv. 2022 Sep 23;8(38):eabq8678. doi: 10.1126/sciadv.abq8678. Epub 2022 Sep 23. PubMed
Differential Ability of Spike Protein of SARS-CoV-2 Variants to Downregulate ACE2. Maeda Y, Toyoda M, Kuwata T, Terasawa H, Tokugawa U, Monde K, Sawa T, Ueno T, Matsushita S. Int J Mol Sci. 2024 Jan 22;25(2):1353. doi: 10.3390/ijms25021353. PubMed
Structural basis for raccoon dog receptor recognition by SARS-CoV-2. Hsueh FC, Shi K, Mendoza A, Bu F, Zhang W, Aihara H, Li F. PLoS Pathog. 2024 May 6;20(5):e1012204. doi: 10.1371/journal.ppat.1012204. eCollection 2024 May. PubMed
Processing of genomic RNAs by Dicer in bat cells limits SARS-CoV-2 replication. Owolabi IJ, Karim SU, Khanal S, Valdivia S, Frenzel C, Bai F, Flynt AS. Virol J. 2025 Mar 25;22(1):86. doi: 10.1186/s12985-025-02693-y. PubMed
Novel Trispecific Neutralizing Antibodies With Enhanced Potency and Breadth Against Pan-Sarbecoviruses. Qiao R, Liu Y, Mao Q, Li J, Lu Y, Shi J, Li C, Yu J, Gong J, Wang X, Shao Y, Sun L, Zhang W, Yu H, Chu H, Wang P, Zhao X. MedComm (2020). 2025 Apr 21;6(5):e70191. doi: 10.1002/mco2.70191. eCollection 2025 May. PubMed

If you have published an article using this material, please email us at to have your article added to this page.